Media

What We Listen To

The Big4Bio Podcast
 

The BioWorld Insider Podcast

Six biopharma executives consider a tough 2023 and are hopeful for a better 2024

One aspect of 2023 our group of executives completely agreed on: the past year was tough financially. And they all foreseee a more vibrant year ahead for the market. Giving all of them hope were technological breakthroughs such as artificial intelligence, game changing weight loss drugs, the surging fascination with ADCs and hope for lower interest rates. But uncertainty looms about the upcoming general election in the U.S. and ground-shifting gene therapies. In a preview of the annual Biotech Showcase conference, an investor conference for private and micro- to mid-cap biotech companies Jan. 8-10 in San Francisco, BioWorld spoke with Dave Bearss, CEO of Halia Therapeutics Inc., Vimal Mehta, CEO of BioXcel Therapeutics Inc., Paul Lammers, CEO at Triumvira Immunologics Inc., Chris Pirie, COO of HDT Bio Corp., Thijs Spoor, CEO of Perspective Therapeutics Inc. and Shelley Hartman, CEO of Aegle Therapeutics Corp. They offered insights brought about by years of hard-won experience.

On the Big4Bio podcast, Demy-Colton's CEO Sara Demy talks about what's in store at Biotech Showcase, now in its 13th year - but virtual for the first time - and how to make the most of it.

Listen to the podcast here.


The top podcasts life science professionals should be listening to.

 

Upcoming Events

07/15-17/24
10/28-30/24
01/13-15/25
01/13-15/25
01/13-15/25